Want to join the conversation?
$STJ receives CE Mark approval for MRI conditional labeling for STJ’s Prodigy MRI chronic pain system with select leads. Upon its launch, Prodigy MRI system will become market’s smallest MR-conditional rechargeable IPG and industry’s sole MR-conditional SCS system capable of delivering both STJ’s proprietary Burst & traditional tonic stimulation.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?